MDA (Medical Devices Agency) eyes Boston stent fractures
This article was originally published in Clinica
The UK Medical Devices Agency (MDA) has warned of the potential radial fracture of coronary stents made by Boston Scientific Scimed, after the company recently reported that there had been nine such incidents since March 2000. Last week's Device Alert affects five NIRoyal (NIR) products, namely the NIR stent, the NIR premounted stent system (PSS), the NIR Advance PSS, the NIR Elite Monorail PSS and the NIR Elite over-the-wire PSS. Around 200,000 Boston NIR stents have been distributed worldwide since they were first marketed in 1998.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.